Works matching IS 20953941 AND DT 2024 AND VI 21 AND IP 11

Results: 9

Deciphering the cell surface glyco-code: a promising perspective on unveiling the vulnerability of cancer stem cells.

Published in:

Cancer Biology & Medicine, 2024, v. 21, n. 11, p. 1, doi. 10.20892/j.issn.2095-3941.2024.0408

By:

Yuanyan Wei;
Anning Wei;
Yirong Li;
Yuerong Yang;
Yu Si;
Yi Li;
Zhijun Fan;
Jianhai Jiang

Publication type:

Article

Tumor-related fungi and crosstalk with gut fungi in the tumor microenvironment.

Published in:

Cancer Biology & Medicine, 2024, v. 21, n. 11, p. 1, doi. 10.20892/j.issn.2095-3941.2024.0240

By:

Yue Wang;
Yiwen Wang;
Yuhang Zhou;
Yun Feng;
Tao Sun;
Junnan Xu

Publication type:

Article

Luteinizing hormone-releasing hormone receptor agonists and antagonists in prostate cancer: effects on long-term survival and combined therapy with next-generation hormonal agents.

Published in:

Cancer Biology & Medicine, 2024, v. 21, n. 11, p. 1012, doi. 10.20892/j.issn.2095-3941.2024.0139

By:

Jinge Zhao;
Junru Chen;
Guangxi Sun;
Pengfei Shen;
Hao Zeng

Publication type:

Article

MicroRNA-384 radiosensitizes human non-small cell lung cancer by impairing DNA damage response and repair signaling, which is inhibited by NF-κB.

Published in:

Cancer Biology & Medicine, 2024, v. 21, n. 11, p. 1, doi. 10.20892/j.issn.2095-3941.2024.0146

By:

Yanchen Sun;
Jing Wang;
Minghan Qiu;
Jinlin Zhao;
Fangdi Zou;
Maobin Meng;
Xiangli Jiang;
Zhiyong Yuan;
Zeyun Mi;
Zhiqiang Wu

Publication type:

Article

From complexity to clarity: development of CHM-FIEFP for predicting effective components in Chinese herbal formulas by using big data.

Published in:

Cancer Biology & Medicine, 2024, v. 21, n. 11, p. 1, doi. 10.20892/j.issn.2095-3941.2023.0442

By:

Boyu Pan;
Han Zhu;
Jiaqi Yang;
Liangjiao Wang;
Zizhen Chen;
Jian Ma;
Bo Zhang;
Zhanyu Pan;
Guoguang Ying;
Shao Li;
Liren Liu

Publication type:

Article

Potential treatment approaches for malignant peritoneal mesothelioma: in vivo and in vitro experimental study of natural killer cell immunotherapy.

Published in:

Cancer Biology & Medicine, 2024, v. 21, n. 11, p. 1050, doi. 10.20892/j.issn.2095-3941.2024.0218

By:

Heliang Wu;
Yi Wang;
Yulin Lin;
Ru Ma;
Xuemei Du;
Yandong Su;
Rui Yang;
Zhiran Yang;
Xinli Liang;
Yinguang Zhang;
Xiaoqing Liang;
Zhonghe Ji;
Chunning Lai;
Yajing Huang;
Yan Li

Publication type:

Article

Impact of immunosuppressants on tumor pulmonary metastasis: new insight into transplantation for hepatocellular carcinoma.

Published in:

Cancer Biology & Medicine, 2024, v. 21, n. 11, p. 1033, doi. 10.20892/j.issn.2095-3941.2024.0267

By:

Jinyan Chen;
Huigang Li;
Jianyong Zhuo;
Zuyuan Lin;
Zhihang Hu;
Chiyu He;
Xiang Wu;
Yiru Jin;
Zhanyi Lin;
Renyi Su;
Yiyang Sun;
Rongsen Wang;
Jiancai Sun;
Xuyong Wei;
Shusen Zheng;
Di Lu;
Xiao Xu

Publication type:

Article

Adenosine signaling in tumor-associated macrophages and targeting adenosine signaling for cancer therapy.

Published in:

Cancer Biology & Medicine, 2024, v. 21, n. 11, p. 1, doi. 10.20892/j.issn.2095-3941.2024.0228

By:

Lei Yang;
Yi Zhang;
Li Yang

Publication type:

Article

PD-1 and LAG-3 dual blockade: emerging mechanisms and potential therapeutic prospects in cancer.

Published in:

Cancer Biology & Medicine, 2024, v. 21, n. 11, p. 970, doi. 10.20892/j.issn.2095-3941.2024.0436

By:

Xiangyu Qiu;
Zhaoan Yu;
Xiaoqing Lu;
Xin Jin;
Jinrong Zhu;
Rongxin Zhang

Publication type:

Article